Nanopore Sequencing in Ophthalmology — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Nanopore Sequencing in Ophthalmology — Stella

Recruiting

Back to Endophthalmitis trials

Trial locations(1 site)

Austria

Universitäts Augenklinik Graz, Graz, Styria

Key details

Sponsor

Medical University of Graz

Enrollment target

~20 participants

Started

April 2022

Primary completion

December 2026

Age range

18 Years – 99 Years

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov